Subscribe To
IPHA / Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update
Content Topics
Innate
Pharma
Announces
Participation
Upcoming
Investor
Conferences
Conference
Business
Update
Stock
IPHA
IPHA News
By Business Wire
October 27, 2023
Innate Pharma Announces Its Participation to Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Business Wire
August 29, 2023
Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Business Wire
June 12, 2023
Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Zacks Investment Research
June 9, 2023
Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag
Innate (IPHA) and Sanofi's SAR'579 / IPH6101 get Fast Track Designation in the United States for the treatment of hematological malignancies. more_horizontal
By The Motley Fool
June 8, 2023
Why Shares of Innate Pharma Jumped Thursday
A therapy Innate Pharma and Sanofi are developing was granted Fast Track Designation by the FDA. Innate Pharma has enough cash to fund operations into more_horizontal
By Business Wire
May 23, 2023
Innate Pharma to Participate in Upcoming Investor Conferences
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Business Wire
May 15, 2023
Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress
MARSEILLE, France--(BUSINESS WIRE)-- #ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced more_horizontal
By Seeking Alpha
May 13, 2023
Innate Pharma SA (IPHA) Q1 2023 Earnings Call Transcript
Innate Pharma SA (NASDAQ:IPHA ) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Henry Wheeler - VP, IR & Communication M more_horizontal
